NCT06024772View on ClinicalTrials.gov

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

February 28, 2027

Conditions
Prostate Carcinoma
Interventions
PROCEDURE

ultiparametric Magnetic Resonance Imaging

Undergo mp-MRI

DRUG

Perflutren lipid microsphere

Given IV

PROCEDURE

Transrectal Ultrasound

Undergo transrectal mp-US

PROCEDURE

Biopsy of Prostate

Undergo prostate biopsies

Trial Locations (2)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

Unknown

Amsterdam Medical Center, Amsterdam-Zuidoost

Sponsors

Collaborators (2)

Eigen
GE Healthcare
All Listed Sponsors
collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

Eindhoven University of Technology

OTHER

collaborator

Eigen

OTHER

collaborator

GE Healthcare

INDUSTRY

lead

Thomas Jefferson University

OTHER